Crossmark Global Holdings’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-11,300
| Closed | -$452K | – | 1279 |
|
2024
Q2 | $452K | Buy |
11,300
+275
| +2% | +$11K | 0.01% | 879 |
|
2024
Q1 | $484K | Sell |
11,025
-194
| -2% | -$8.52K | 0.01% | 882 |
|
2023
Q4 | $694K | Sell |
11,219
-194
| -2% | -$12K | 0.01% | 719 |
|
2023
Q3 | $548K | Buy |
11,413
+168
| +1% | +$8.07K | 0.01% | 784 |
|
2023
Q2 | $684K | Sell |
11,245
-259
| -2% | -$15.8K | 0.01% | 714 |
|
2023
Q1 | $432K | Sell |
11,504
-107
| -0.9% | -$4.02K | 0.01% | 892 |
|
2022
Q4 | $325K | Buy |
11,611
+330
| +3% | +$9.24K | 0.01% | 986 |
|
2022
Q3 | $317K | Buy |
11,281
+129
| +1% | +$3.63K | 0.01% | 968 |
|
2022
Q2 | $387K | Buy |
+11,152
| New | +$387K | 0.01% | 924 |
|